DMK Pharmaceuticals Corp
OTC:DMKPQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
DMK Pharmaceuticals Corp
OTC:DMKPQ
|
US |
|
S
|
Stanley Agricultural Group Co Ltd
SZSE:002588
|
CN |
|
AGNC Investment Corp
NASDAQ:AGNC
|
US |
|
N
|
NEC Corp
XHAM:NEC1
|
JP |
|
Azucar Minerals Ltd
XTSX:AMZ
|
CA |
|
China Resources Mixc Lifestyle Services Ltd
HKEX:1209
|
CN |
|
Permanent TSB Group Holdings PLC
LSE:PTSB
|
IE |
|
Amlogic Shanghai Co Ltd
SSE:688099
|
CN |
|
Gold Resource Corp
LSE:0IYS
|
US |
|
SASA Polyester Sanayi AS
IST:SASA.E
|
TR |
|
D
|
D-Wave Quantum Inc
NYSE:QBTS
|
CA |
|
H
|
Haldex AB
LSE:0O93
|
SE |
|
Miricor Enterprises Holdings Ltd
HKEX:1827
|
HK |
|
V
|
Vsolar Group Bhd
KLSE:VSOLAR
|
MY |
|
Is Yatirim Menkul Degerler AS
IST:ISMEN.E
|
TR |
|
B
|
Bank Raya Indonesia Tbk PT
XBER:0R8
|
ID |
|
Fukuyama Transporting Co Ltd
TSE:9075
|
JP |
|
Digital China Holdings Ltd
HKEX:861
|
HK |
|
Bunker Hill Mining Corp
OTC:BHLL
|
CA |
|
IF Bancorp Inc
NASDAQ:IROQ
|
US |
|
Beijing YJK Building Software Co Ltd
SZSE:300935
|
CN |
|
S
|
Shaanxi Lighte Optoelectronics Material Co Ltd
SSE:688150
|
CN |
|
C
|
Chinese Universe Publishing and Media Group Co Ltd
SSE:600373
|
CN |
|
H
|
Huarui Electrical Appliance Co Ltd
SZSE:300626
|
CN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of DMKPQ.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
DMKPQ Competitors Multiples
DMK Pharmaceuticals Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
DMK Pharmaceuticals Corp
OTC:DMKPQ
|
10 USD | 0 | -0 | 0.3 | 0.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13 | 41.1 | 27.7 | 29.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
576.1B USD | 6.1 | 21.5 | 14.9 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.4 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.1 | 10 | 12.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 4.9 | 28.1 | 15.6 | 22 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 2.5 | 17 | 7.2 | 8.8 |